Article Information
History
- July 11, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
- 2Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
- 3School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK
- 4NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
- 5COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK
- ↵*Correspondence:
Prof Manoj Sivan MD FRCP, Clinical Professor and Honorary Consultant, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Floor D Martin Wing, Leeds General Infirmary, LS1 3EX, Tel +44 (0)113 3922564, Email M.Sivan{at}leeds.ac.uk
Posted July 11, 2024.
New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria
